基金概述
State Street Health Care Select Sector SPDR ETF (XLV) is a health sector exchange-traded fund managed by State Street Investment Management, positioning it as a primary vehicle for gaining exposure to the healthcare industry. With total assets under management reaching $43.12B, the fund operates at a significant scale that suggests substantial popularity among institutional and retail participants seeking sector-specific allocation. Although the specific number of holdings is not disclosed in the available data, the substantial asset base implies a robust structure designed to track the healthcare sector broadly. The fund maintains an expense ratio of 0.1%, which is conceptually low compared to many actively managed peers, indicating that management fees are minimal relative to the fund's massive size and likely to have a negligible impact on total return calculations.
业绩分析
The current yield stands at 1.6%, a metric that provides a baseline income stream for investors seeking regular cash distributions alongside potential capital appreciation from healthcare equities. Year-to-date, the fund has recorded a return of 3.5%, reflecting short-term market movements within the healthcare sector during the current fiscal year. Over longer horizons, the 3-year average return is 5.6%, while the 5-year average return is 5.8%, indicating a consistent performance trajectory that suggests the fund has maintained stability over multi-year cycles. Comparing the short-term YTD return of 3.5% against the 5-year average of 5.8% reveals that recent performance has been lower than the historical five-year mean, suggesting the fund has experienced a period of underperformance relative to its long-term historical consistency. The expense ratio of 0.1% further supports net returns over time by ensuring that a significant portion of the fund's gross gains is retained by investors rather than consumed by administrative costs, thereby enhancing the efficiency of the investment vehicle.
Price & Risk Profile
The fund's price has fluctuated between a 52-week low of $127.35 and a 52-week high of $160.59, defining a trading range that illustrates the volatility experienced by healthcare equities over the past year. Based on these extremes, the current price sits approximately in the upper half of the 52-week range, indicating that the asset has traded above its yearly average price for a significant portion of the period. The beta value is not available in the provided data, so a direct quantitative comparison of volatility relative to the broader market cannot be made based on this specific metric. Consequently, the overall risk profile must be assessed primarily through the observed price range and historical returns, where the 5.8% five-year average return combined with a 0.1% expense ratio suggests a moderate risk environment typical of large-cap sector funds, though the absence of a beta figure limits the precision of volatility quantification relative to the broader index.